The U.S. Department of Labor renewed the ‘star level’ designation for Pfizer's Andover site for workplace safety and health achievements.
Pfizer employs about 1,700 workers at the Andover location, which produces biotherapeutic pharmaceuticals. Employees conduct research and development and manufacture recombinant DNA-derived protein therapeutics and vaccines.
The site uses a wide variety of hazard assessment and control tools to protect worker safety and health such as qualitative risk assessment, job hazard analysis, biological safety, ergonomics and chemical safety.
OSHA first recognized Pfizer Andover in 2007 with the highest level of recognition that the agency’s Voluntary Protection Programs offers. The facility earned its VPP star renewal following an onsite evaluation in October 2021 by a team of OSHA safety and health experts. This VPP worksite played a key role in the Pfizer corporation’s response to the COVID-19 pandemic.
“The site’s management leadership and employee engagement to eliminate hazards and improve work activities at Pfizer Andover is exceptional," OSHA Regional Administrator Galen Blanton said. "This includes participation in the site’s several safety and health committees and teams covering contractor, laboratory, electrical, hazardous energy control and fall safety.”